Caption Management, LLC
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1706766
OKLAHOMA CITY, OK
Position in KNSA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,598,750
+$1,598,750 QoQ
Shares Held
25,000
Ownership
0.016%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#105
of 264 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Derivatives in KNSA
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$19,172,210
PutShares
299,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caption Management, LLC holds $32,819,609 across 14 Drug Manufacturers - Specialty & Generic names. KNSA ranks #6 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
258,331 | $8,752,254 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
9,333 | $5,056,899 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
29,500 | $4,971,930 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
40,000 | $3,311,200 | |
| 5 | PRGO |
PERRIGO Co plc
|
253,459 | $2,633,439 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
25,000 | $1,598,750 | |
| 7 | XERS |
Xeris Biopharma Holdings, Inc.
|
197,863 | $1,567,074 | |
| 8 | EOLS |
Evolus, Inc.
|
216,316 | $1,501,233 |
All Filings in KNSA
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,172,210 | 299,800 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $1,598,750 | 25,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $48,121,110 | 999,400 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $61,483,125 | 1,490,500 | Call | Sole | 2026-02-17 | |
| 2025-09-30 | $3,494,700 | 90,000 | Put | Sole | 2025-11-14 | |
| 2025-09-30 | $19,515,958 | 502,600 | Call | Sole | 2025-11-14 | |
| 2025-06-30 | $6,364,100 | 230,000 | Call | Sole | 2025-08-14 | |
| 2025-06-30 | $31,612,975 | 1,142,500 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $666,300 | 30,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $666,300 | 30,000 | Put | Sole | 2025-05-15 | |
| 2024-09-30 | $749,700 | 30,000 | Call | Sole | 2024-11-14 | |
| 2024-09-30 | $749,700 | 30,000 | Put | Sole | 2024-11-14 | |
| 2024-06-30 | $75,893 | 4,065 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||